ARHGAP27 Antikörper (Middle Region)
Kurzübersicht für ARHGAP27 Antikörper (Middle Region) (ABIN954792)
Target
Alle ARHGAP27 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 197-226, Middle Region
-
Spezifität
- Recognizes SH3D20 (Center).
-
Aufreinigung
- Protein A column followed by peptide Affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 197-226 amino acids from the Central region of Human SH3D20 Genename: ARHGAP27
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ARHGAP27 (rho GTPase Activating Protein 27 (ARHGAP27))
-
Andere Bezeichnung
- SH3D20
-
Hintergrund
- SH3D20 is a rho GTPase-activating protein which may be involved in clathrin-mediated endocytosis. GTPase activators for the Rho-type GTPases act by converting them to an inactive GDP-bound state. Has activity toward CDC42 and RAC1 (By similarity).Synonyms: ARHGAP27, CAMGAP1, Rho GTPase-activating protein 27
-
Gen-ID
- 201176
-
NCBI Accession
- NP_777579
Target
-